Menopause commonly causes hot flushes, mood changes and sleep disruption. This article summarises established medical treatments—especially hormone therapy—and complementary options to help women and clinicians choose safe, effective symptom management.
Oestrogen (with progesterone when indicated) is the single most effective treatment for vasomotor and sleep symptoms and often improves mood and daily function. Treatment choice balances symptom severity, likely benefit and individual health risks.
Options differ by formulation and route; the main categories are:
Clinicians select therapy based on symptoms, medical history and patient preference, and monitor effectiveness and safety. UCO Medical Clinic evaluates patients to guide choice.
BHRT differs in hormone source and molecular similarity; some patients report improved tolerance. Traditional HRT has more long‑term trial evidence; both require individual risk–benefit discussion.
Debate continues about comparative safety, particularly cardiovascular effects, so individual assessment is essential.
Bio-Identical HRT: Cardiovascular Risks & Safety Appraisal
Recent clinical trials have reported an increased risk of cardiovascular disease (CVD) in women using oral hormone replacement therapy (HRT). Bio‑identical HRT (BHRT) is widely used by alternative practitioners with the assumption that it preserves HRT benefits while reducing risk. However, given the serious risks identified with HRT, using any form of HRT—including BHRT—without sufficient scientific evaluation may create considerable risk.
Is bio-identical hormone replacement therapy safer than traditional hormone replacement therapy? A critical appraisal of cardiovascular risks in menopausal women, 2006
Key benefits are strong symptom relief, improved bone density and often better quality of life. Important risks to monitor include thromboembolism, potential increased breast cancer risk with long use, and cardiovascular effects in susceptible women.
| Benefit | Risk | Impact Level |
|---|---|---|
| Symptom relief | Increased risk of blood clots | Moderate |
| Improved bone health | Breast cancer concerns | High |
| Enhanced quality of life | Cardiovascular issues | Moderate |
Discuss benefits and risks with a clinician to align treatment with health priorities and individual risk profile.
Medical treatment targets vasomotor symptoms (hot flushes, night sweats), sleep disruption and mood instability. Hormone therapy is most effective for vasomotor symptoms; other medical and behavioural treatments support mood and sleep.
Individualised, combined plans usually give the best symptom control and functional gains.
Management mixes medical and lifestyle strategies: targeted hormone regimens when appropriate, exercise, diet adjustments and sleep hygiene. Non‑hormonal medicines used in selected patients include SSRIs/SNRIs, gabapentin and clonidine.
For women who cannot or prefer not to use hormones, non‑hormonal strategies can still provide meaningful relief for hot flushes and related symptoms.
Non-Hormonal Strategies for Menopausal Hot Flashes
Vasomotor symptoms, particularly hot flushes (HFs), are the most frequently reported complaint among menopausal women. In younger women with treatment‑induced premature ovarian failure (for example, after cancer therapy), severe HFs may significantly impair quality of life. Optimal management requires a personalised approach to identify the treatment with the best benefit/risk profile for each woman. Hormone replacement therapy (HRT) effectively manages HFs but is contraindicated in women with prior hormone‑dependent cancer; many healthy women also prefer non‑hormonal strategies.
Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update, N Biglia, 2019
Oestrogen preserves bone density and can reduce fracture risk when used per guidelines. Hormone therapy may also relieve fatigue related to hormonal change and improve daily energy for many women.
Complementary approaches can support clinical care. Lower‑risk options include dietary changes, regular exercise and stress‑management techniques.
Use complementary therapies as adjuncts and discuss benefits and limitations with a healthcare provider.
Some evidence supports phytoestrogens, black cohosh and red clover, though responses vary. Practical lifestyle measures—weight control, hydration and avoiding triggers such as caffeine and alcohol—also reduce vasomotor episodes.
Many women explore phytoestrogens and other natural options when concerned about traditional HRT; discuss these choices with a clinician.
Phytoestrogens as Alternative for Menopausal Vasomotor Symptoms
Vasomotor symptoms, such as hot flushes and night sweats, are very common during the menopausal transition. Hormone therapy has traditionally been used as a highly effective treatment, but concerns about increased risk of some chronic diseases have markedly increased interest in alternative treatments. Some of the most popular are foods or supplements enriched with phytoestrogens—plant‑derived chemicals that have oestrogenic action.
Phytoestrogens for menopausal vasomotor symptoms, 2013
Complementary care addresses nutrition, behaviour and psychosocial needs and works best when coordinated with clinical care. Multidisciplinary support can improve outcomes and long‑term quality of life.
Cost affects access and choice; check insurance, out‑of‑pocket expenses and long‑term costs when planning care.
Discuss pricing and payment options with your healthcare team to find affordable, appropriate pathways.
Costs vary by formulation and provider. Typical ranges reported are:
Know approximate costs and discuss alternatives if affordability is a concern.
UCO Medical Clinic reduces access barriers by prioritising underinsured patients and offering telehealth, insurance coordination and flexible payment options.
Common side effects include bloating, breast tenderness, mood changes and headaches; some women report bleeding changes or libido shifts. Clinicians monitor and adjust therapy to reduce side effects.
Duration depends on symptoms and risk. Use the lowest effective dose for the shortest necessary period, with regular review.
Alternatives include acupuncture, herbal supplements and mindfulness. Evidence varies; consider them as adjuncts and discuss with a clinician.
A balanced diet supports overall health; phytoestrogen foods (soy, flax) may help some women. Hydration and limiting caffeine and alcohol can reduce vasomotor triggers.
Mental health is important—hormonal changes can affect mood. Counselling, support groups and stress‑management techniques can help.
Aerobic activity, strength training and flexibility/balance exercises (walking, swimming, weight training, yoga) support bone, cardiovascular and mental health.
Regular exercise, a balanced diet (including phytoestrogen‑rich foods when appropriate), stress management and avoiding triggers like caffeine and alcohol help reduce hot flushes and support sleep and mood.
Yes. SSRIs/SNRIs, gabapentin and clonidine can reduce hot flushes or improve mood when hormones are not suitable.
Suitability requires clinical review of medical history, cancer and cardiovascular risks, symptom severity and relevant tests. Discuss risks and benefits with a clinician.
Phytoestrogens are plant compounds with mild oestrogenic activity that may reduce hot flushes for some women; evidence is mixed—consult your clinician.
Peer groups, counselling, programmes and online communities offer emotional support and coping strategies; clinicians can refer to local resources.
Consider medical history, symptom profile, evidence and cost. BHRT allows some customisation; traditional HRT has broader long‑term data—seek clinician guidance.
Personalised management of menopausal symptoms improves function and quality of life. Review benefits, risks and complementary options with a qualified clinician to develop a safe, individualised plan.
Understanding treatment benefits and risks—alongside lifestyle approaches—helps women make informed choices. Consult a qualified clinician to create a safe, effective symptom‑management plan and start targeted relief.
Author: Yukhanan Benjamin, MD PH.D. Florida licensed physician